|
[1]
|
Braun, C.I., Freidlin, V., Sperduto, R.D., et al. (1996) The Progression of Myopia in School Age Children: Data from the Columbia Medical Plan. Ophthalmic Epidemiology, 3, 13-21. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Elnahry, A.G., Khafagy, M.M., Esmat, S.M., et al. (2019) Prevalence and Associations of Posterior Segment Manifestations in a Cohort of Egyptian Patients with Pathological Myopia. Current Eye Research, 44, 955-962. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Huang, J., Wen, D., Wang, Q., et al. (2016) Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-Analysis. Ophthalmology, 123, 697-708. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Morgan, I.G., French, A.N., Ashby, R.S., et al. (2018) The Epidemics of Myopia: Aetiology and Prevention. Progress in Retinal and Eye Research, 62, 134-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Upadhyay, A. and Beuerman, R.W. (2020) Biological Mechanisms of Atropine Control of Myopia. Eye & Contact Lens, 46, 129-135. [Google Scholar] [CrossRef]
|
|
[6]
|
Mcbrien, N.A., Moghaddam, H.O. and Reeder, A.P. (1993) Atropine Reduces Experimental Myopia and Eye Enlargement via a Nonaccommodative Mechanism. Investigative Ophthalmology & Visual Science, 34, 205-215.
|
|
[7]
|
Barathi, V.A. and Beuerman, R.W. (2011) Molecular Mechanisms of Muscarinic Receptors in Mouse Scleral Fibroblasts: Prior to and after Induction of Experimental Myopia with Atropine Treatment. Molecular Vision, 17, 680-692.
|
|
[8]
|
Avetisov, E.S., Savitskaya, N.F., Vinetskaya, M.I., et al. (1983) A Study of Biochemical and Biomechanical Qualities of Normal and Myopic Eye Sclera in Humans of Different Age Groups. Metabolic, Pediatric, and Systemic Ophthalmology, 7, 183-188.
|
|
[9]
|
Rada, J.A., Nickla, D.L. and Troilo, D. (2000) Decreased Proteoglycan Synthesis Associated with Form Deprivation Myopia in Mature Primate Eyes. Investigative Ophthalmology & Visual Science, 41, 2050-2058.
|
|
[10]
|
Gallego, P., Martínez-García, C., Pérez-Merino, P., et al. (2012) Scleral Changes Induced by Atropine in Chicks as an Experimental Model of Myopia. Ophthalmic and Physiological Optics, 32, 478-484. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hsiao, Y.T., Chang, W.A., Kuo, M.T., et al. (2019) Systematic Analysis of Transcriptomic Profile of the Effects of Low Dose Atropine Treatment on Scleral Fibroblasts Using Next-Generation Sequencing and Bioinformatics. International Journal of Medical Sciences, 16, 1652-1667. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Barathi, V.A., Chaurasia, S.S., Poidinger, M., et al. (2014) Involvement of GABA Transporters in Atropine-Treated Myopic Retina as Revealed by ITRAQ Quantitative Proteomics. Journal of Proteome Research, 13, 4647-4658. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chua, W.H., Balakrishnan, V., Chan, Y.H., et al. (2006) Atropine for the Treatment of Childhood Myopia. Ophthalmology, 113, 2285-2291. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Song, Y.Y., Wang, H., Wang, B.S., et al. (2011) Atropine in Ameliorating the Progression of Myopia in Children with Mild to Moderate Myopia: A Meta-Analysis of Controlled Clinical Trials. Journal of Ocular Pharmacology and Therapeutics, 27, 361-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chia, A., Chua, W.H., Cheung, Y.B., et al. (2012) Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2). Ophthalmology, 119, 347-354. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Chia, A., Chua, W.H., Wen, L., et al. (2014) Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%, 0.1% and 0.5%. American Journal of Ophthalmology, 157, 451-457.E1. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Chia, A., Lu, Q.S. and Tan, D. (2016) Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eye Drops. Ophthalmology, 123, 391-399. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yam, J.C., Jiang, Y., Tang, S.M., et al. (2019) Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 126, 113-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Yam, J.C., Li, F.F., Zhang, X., et al. (2020) Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology, 127, 910-919. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Hieda, O., Hiraoka, T., Fujikado, T., et al. (2021) Efficacy and Safety of 0.01% Atropine for Prevention of Childhood Myopia in a 2-Year Randomized Placebo-Controlled Study. Japanese Journal of Ophthalmology, 65, 315-325. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Tan, D.T., Lam, D.S., Chua, W.H., et al. (2005) One-Year Multicenter, Double-Masked, Placebo-Controlled, Parallel Safety and Efficacy Study of 2% Pirenzepine Ophthalmic Gel in Children with Myopia. Ophthalmology, 112, 84-91. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Siatkowski, R.M., Cotter, S.A., Crockett, R.S., et al. (2008) Two-Year Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Safety and Efficacy Study of 2% Pirenzepine Ophthalmic Gel in Children with Myopia. Journal of AAPOS, 12, 332-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Arumugam, B. and Mcbrien, N.A. (2012) Muscarinic Antagonist Control of Myopia: Evidence for M4 and M1 Receptor-Based Pathways in the Inhibition of Experimentally-Induced Axial Myopia in the Tree Shrew. Investigative Ophthalmology & Visual Science, 53, 5827-5837. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Trier, K., Olsen, E.B., Kobayashi, T., et al. (1999) Biochemical and Ultrastructural Changes in Rabbit Sclera after Treatment with 7-Methylxanthine, Theobromine, Acetazolamide, or L-Ornithine. British Journal of Ophthalmology, 83, 1370-1375. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Trier, K., Munk Ribel-Madsen, S., Cui, D., et al. (2008) Systemic 7-Methylxanthine in Retarding Axial Eye Growth and Myopia Progression: A 36-Month Pilot Study. Journal of Ocular Biology, Diseases, and Informatics, 1, 85-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Trier, K., Cui, D., Ribel-Madsen, S., et al. (2022) Oral Administration of Caffeine Metabolite 7-Methylxanthine Is Associated with Slowed Myopia Progression in Danish Children. British Journal of Ophthalmology, 107, 1538-1544. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Quinn, G.E., Berlin, J.A., Young, T.L., et al. (1995) Association of Intraocular Pressure and Myopia in Children. Ophthalmology, 102, 180-185. [Google Scholar] [CrossRef]
|
|
[28]
|
蔡晓静, 朱煌, 冯彦青. 葛根素滴眼液对青少年近视眼的作用[J]. 中国中医眼科杂志, 2013, 23(5): 340-343.
|
|
[29]
|
Rosenfield, M. and Gilmartin, B. (1987) Beta-Adrenergic Receptor Antagonism in Myopia. Ophthalmic and Physiological Optics, 7, 359-364. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Schmid, K.L., Abbott, M., Humphries, M., et al. (2000) Timolol Lowers Intraocular Pressure but Does Not Inhibit the Development of Experimental Myopia in Chick. Experimental Eye Research, 70, 659-666. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Liu, Y., Wang, Y., Lv, H., et al. (2017) α-Adrenergic Agonist Brimonidine Control of Experimentally Induced Myopia in Guinea Pigs: A Pilot Study. Molecular Vision, 23, 785-798.
|
|
[32]
|
Yang, Y., Wu, J., Wu, D., et al. (2021) Intravitreal Brimonidine Inhibits Form-Deprivation Myopia in Guinea Pigs. Eye and Vision (London), 8, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
El-Nimri, N.W. and Wildsoet, C.F. (2018) Effects of Topical Latanoprost on Intraocular Pressure and Myopia Progression in Young Guinea Pigs. Investigative Ophthalmology & Visual Science, 59, 2644-2651. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Yang, J., Pan, M., Reinach, P.S., et al. (2018) Prostaglandin F2α Receptor Modulation Affects Eye Development in Guinea Pigs. Basic & Clinical Pharmacology & Toxicology, 123, 263-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
高峻. 卡替洛尔联合阿托品治疗青少年近视的效果[J]. 中国城乡企业卫生, 2022, 37(12): 132-133.
|
|
[36]
|
Stone, R.A., Lin, T., Laties, A.M., et al. (1989) Retinal Dopamine and Form-Deprivation Myopia. Proceedings of the National Academy of Sciences of the United States of America, 86, 704-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Weiss, S. and Schaeffel, F. (1993) Diurnal Growth Rhythms in the Chicken Eye: Relation to Myopia Development and Retinal Dopamine Levels. Journal of Comparative Physiology A, 172, 263-270. [Google Scholar] [CrossRef]
|
|
[38]
|
Zhou, X., An, J., Wu, X., et al. (2010) Relative Axial Myopia Induced by Prolonged Light Exposure in C57BL/6 Mice. Photochemistry and Photobiology, 86, 131-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Landis, E.G., Chrenek, M.A., Chakraborty, R., et al. (2020) Increased Endogenous Dopamine Prevents Myopia in Mice. Experimental Eye Research, 193, Article ID: 107956. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
邱宇, 高洪莲, 于睿, 等. 抗血管内皮生长因子玻璃体内注射对形觉剥夺性近视豚鼠视网膜中多巴胺水平的影响[J]. 眼科新进展, 2022, 42(2): 113-117.
|
|
[41]
|
Thomson, K., Karouta, C. and Ashby, R. (2020) Topical Application of Dopaminergic Compounds Can Inhibit Deprivation Myopia in Chicks. Experimental Eye Research, 200, Article ID: 108233. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Thomson, K., Morgan, I., Kelly, T., et al. (2021) Coadministration with Carbidopa Enhances the Antimyopic Effects of Levodopa in Chickens. Investigative Ophthalmology & Visual Science, 62, 25. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Thomson, K., Karouta, C. and Ashby, R. (2020) Form-Deprivation and Lens-Induced Myopia Are Similarly Affected by Pharmacological Manipulation of the Dopaminergic System in Chicks. Investigative Ophthalmology & Visual Science, 61, 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zhou, X., Zhang, S., Zhang, G., et al. (2020) Increased Choroidal Blood Perfusion Can Inhibit Form Deprivation Myopia in Guinea Pigs. Investigative Ophthalmology & Visual Science, 61, 25. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Yan, T., Xiong, W., Huang, F., et al. (2015) Daily Injection But Not Continuous Infusion of Apomorphine Inhibits Form-Deprivation Myopia in Mice. Investigative Ophthalmology & Visual Science, 56, 2475-2485. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Zhang, S., Yang, J., Reinach, P.S., et al. (2018) Dopamine Receptor Subtypes Mediate Opposing Effects on Form Deprivation Myopia in Pigmented Guinea Pigs. Investigative Ophthalmology & Visual Science, 59, 4441-4448. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Huang, F., Wang, Q., Yan, T., et al. (2020) The Role of the Dopamine D2 Receptor in Form-Deprivation Myopia in Mice: Studies with Full and Partial D2 Receptor Agonists and Knockouts. Investigative Ophthalmology & Visual Science, 61, 47. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Ward, A.H., Siegwart, J.T., Frost, M.R., et al. (2017) Intravitreally-Administered Dopamine D2-Like (and D4), but Not D1-Like, Receptor Agonists Reduce Form-Deprivation Myopia in Tree Shrews. Visual Neuroscience, 34, E003. [Google Scholar] [CrossRef]
|
|
[49]
|
Mccarthy, C.S., Megaw, P., Devadas, M., et al. (2007) Dopaminergic Agents Affect the Ability of Brief Periods of Normal Vision to Prevent Form-Deprivation Myopia. Experimental Eye Research, 84, 100-107. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Parisi, V., Centofanti, M., Ziccardi, L., et al. (2015) Treatment with Citicoline Eye Drops Enhances Retinal Function and Neural Conduction along the Visual Pathways in Open Angle Glaucoma. Graefe’s Archive for Clinical and Experimental Ophthalmology, 253, 1327-1340. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Rejdak, R., Toczołowski, J., Solski, J., et al. (2002) Citicoline Treatment Increases Retinal Dopamine Content in Rabbits. Ophthalmic Research, 34, 146-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Mao, J., Liu, S. and Fu, C. (2016) Citicoline Retards Myopia Progression Following Form Deprivation in Guinea Pigs. Experimental Biology and Medicine (Maywood), 241, 1258-1263. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Caporossi, A., Mazzotta, C., Baiocchi, S., et al. (2010) Long-Term Results of Riboflavin Ultraviolet a Corneal Collagen Cross-Linking for Keratoconus in Italy: The Siena Eye Cross Study. American Journal of Ophthalmology, 149, 585-593. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Dotan, A., Kremer, I., Gal-Or, O., et al. (2016) Scleral Cross-Linking Using Riboflavin and Ultraviolet—A Radiation for Prevention of Axial Myopia in a Rabbit Model. Journal of Visualized Experiments, No. 110, e53201. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Liu, S., Li, S., Wang, B., et al. (2016) Scleral Cross-Linking Using Riboflavin UVA Irradiation for the Prevention of Myopia Progression in a Guinea Pig Model: Blocked Axial Extension and Altered Scleral Microstructure. PLOS ONE, 11, e0165792. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Fledelius, H., Zak, M. and Pedersen, F.K. (2001) Refraction in Juvenile Chronic Arthritis: A Long-Term Follow-Up Study, with Emphasis on Myopia. Acta Ophthalmologica Scandinavica, 79, 237-239. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Lin, H.J., Wei, C.C., Chang, C.Y., et al. (2016) Role of Chronic Inflammation in Myopia Progression: Clinical Evidence and Experimental Validation. EBioMedicine, 10, 269-281. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Wang, F., Zhou, J., Lu, Y., et al. (2011) Effects of 530 nm Green Light on Refractive Status, Melatonin, MT1 Receptor, and Melanopsin in the Guinea Pig. Current Eye Research, 36, 103-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Rada, J.A. and Wiechmann, A.F. (2006) Melatonin Receptors in Chick Ocular Tissues: Implications for a Role of Melatonin in Ocular Growth Regulation. Investigative Ophthalmology & Visual Science, 47, 25-33. [Google Scholar] [CrossRef] [PubMed]
|